DXR vs BDX

For growth investors, Becton, Dickinson and Company (BDX) is the stronger pick with 8.

2% revenue growth year-over-year, versus -93. 8% for Daxor Corporation (DXR). Becton, Dickinson and Company (BDX) offers the better valuation at 26. 3x trailing P/E (12. 3x forward), making it the more compelling value choice. Analysts rate Becton, Dickinson and Company (BDX) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Becton, Dickinson and Company (BDX) is the cheapest at 26.

3x versus Daxor Corporation at 87. 8x.

Over the past 5 years, Becton, Dickinson and Company (BDX) delivered a total return of +16.

9%, compared to +3. 3% for Daxor Corporation (DXR). Over 10 years, the gap is even starker: BDX returned +80. 2% versus DXR's +21. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Daxor Corporation (DXR) is the lower-risk stock at 0.

33β versus Becton, Dickinson and Company's 0. 66β — meaning BDX is approximately 100% more volatile than DXR relative to the S&P 500. On balance sheet safety, Daxor Corporation (DXR) carries a lower debt/equity ratio of 2% versus 76% for Becton, Dickinson and Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Becton, Dickinson and Company (BDX) is pulling ahead at 8.

2% versus -93. 8% for Daxor Corporation (DXR). On earnings-per-share growth, the picture is similar: Daxor Corporation grew EPS 81. 5% year-over-year, compared to -0. 5% for Becton, Dickinson and Company. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Daxor Corporation (DXR) is the more profitable company, earning 25.

2% net margin versus 7. 7% for Becton, Dickinson and Company — meaning it keeps 25. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DXR leads at 29. 2% versus 11. 8% for BDX. At the gross margin level — before operating expenses — DXR leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, BDX (2.

7% yield) pays a dividend. DXR does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Becton, Dickinson and Company (BDX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

66), 2. 7% yield). Both have compounded well over 10 years (BDX: +80. 2%, DXR: +21. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

BDX pays a dividend while DXR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.